HAVCR2 and neoplasm: In patients with NSCLC PD-1, TIM-3, CTLA-4, LAG-3, and BTLA inhibitory receptors were detected on TILs with a gradual and continuous upregulation during tumor progression, in 24 tumor lesions (24).